There are no big surprises in the Q2’21 financials of Asarina Pharma.
Redeye states that while sales came in lower than expectations, the company continues to impress on ...
Redeye comments on Azelio’s largest order to date, corresponding to 20 TES.
The lead project Orviglance (also called Mangoral, an improved contrast agent addressing liver metastases) is slightly delayed by up to 6m d...
Redeye remains positive to Fortnox following a Q2 report matching our expectations, with record-high...
Redeye first comments on Dignitana's Q2 report. The sales development continues to be strong with a ...
Omsättningen i Q2'21 uppgick till EUR 8,8m vs våra estimat om 8,6m.
Redeye states that while numbers were slightly below our expectations, we still argue that the repor...
Beijer Group posted a record order intake in Q2’21 of more than half a billion SEK.
Redeye was really surprised to see the weak Q2 numbers showing significantly lower revenues and nega...
Redeye highlights that Calliditas continue to progress with the lead candidate Nefecon and the compa...
We expect Sparekassen Kronjylland to continue to benefit from the current sector tailwinds – a strong economic recovery and high activity le...
Nettoomsättningen i Q2'21 uppgick till 480 mkr vs våra estimat om 418 mkr.
Redeye comments on OssDsign’s Q2 report and emphasizes that activities during and after the quarter ...
Redeye views the Q2 report, with record sales and a strong pipeline, as a strong sign of the company progressing according to plan.
Due to some delays and changes the production guidance for 2021 was lowered to around 1,500 oz (prev...
Balco’s Q2 report showed a clear pick-up in order intake, although sales and earnings are still belo...
Cantargia reported its Q2 numbers this morning with an operating loss of SEK -86.
Q2 adj. EBIT SEK 71m, +5% vs. ABGSCe Encouraging recovery in transaction-based sales Expect positive...
Idag offentliggjorde Ecoclime sin delårsrapport för andra kvartalet 2021.
Redeye's first comments on Scibase's Q2 report. The sales were slightly lower than expected; however, the sales levels are still small, and ...
Redeye is positive about Tuesday’s press release from aXichem, where it announced it has fully verif...
DistIT Group has announced the acquisition of Efuel, a Swedish market leader (30% share) within the ...
Cibus’ strategy proceeds according to plan and further Nordic expansion seems inevitable.
CDON had a difficult H1, including issues with site traffic, down 37% y/y in Q2 (3P GMV growth of 4%...
Netcompany's Q2 report was a mixed bag with the key question being whether it was more important tha...
Marimekko’s Q2 results came in above our and consensus’ estimates.
Cibus's Q2 income from property management (IFPM) was slightly better than Infront consensus but som...
Raketech's Q2 report was 2% above our expectations on EBITDA, posting strong organic growth of 25.
